[1] |
陆再英,钟南山.内科学[M].7 版.北京:人民卫生出版社,2008:274. |
[2] |
Khuseyinova N,Koenig W.Predicting the risk of cardiovascular disease:where does lipoprotein-associated phospholipase A(2) fit in?[J].Mol Diagn Ther,2007,11(4):203-217. |
[3] |
Papathanasiou AI,Lourida ES,Tsironis LD,et al.Short-and long-term elevation of autoantibody titers against oxidized LDL in patients with acute corcnay syndromes.Role of the lipoprotein-associated phospholipase A2 and the effect of atorvastatin treatment[J].Atherosclerosis,2008,196(1):289-297. |
[4] |
Tselepis AF,Rizzo M,Goudevenos IA.Therapeutic modulation of lipoprotein-associated phospholipase A2(Lp-PLA2)[J].Curr Pharm Des,2011,17(33):3656-3661. |
[5] |
Ronti T,Lupattelli G,Mannarino E.The endocrine function of adipose tissue:an update[J].Clin Endocrinol(Oxf),2006,64(4):355-365. |
[6] |
刘更夫,左华泽,骆明波,等.血清视黄醇结合蛋白4水平与动脉粥样硬化危险因素的相关性分析[J].微循环学杂志,2009,19(3):61-63. |
[7] |
谢玉婷,汪年松.视黄醇结合蛋白4与心血管疾病的研究进展[J/CD].中华临床医师杂志:电子版,2011,5(6):1698-1700. |
[8] |
张敏,唐荣珍,曹晓江,等.冠心病合并2型糖尿病血清视黄醇结合蛋白4水平与冠状动脉病变程度的相关性研究[J].华西医学,2011,26(12):1818-1821. |
[9] |
周海艳,岳晓丽,石建华.视黄醇结合蛋白4与老年2型糖尿病视网膜病变的相关性研究[J].蚌埠医学院学报,2013,38(7):803-808. |
[10] |
洪衡,王明生,王河,等.不同类型急性心肌梗死冠状动脉病变特点的观察[J].中国循环杂志,2007,22(3):187-190. |
[11] |
时永辉,牛冬梅,吴嘉,等.冠心病患者血清脂蛋白相关磷脂酶A2与氧化低密度脂蛋白水平[J].临床检验杂志,2013,31(2):92-95. |